Skip to main content
SCTX
NASDAQ Life Sciences

Scribe Therapeutics Prices Upsized $128.7M IPO at $15/Share, Adds Sanofi Placement

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
--
Mkt Cap
--
52W Low
--
52W High
--
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

Scribe Therapeutics priced its upsized IPO at $15.00 per share, the high end of the range, raising $128.7 million from 8.58 million shares. Sanofi is buying 500,000 shares in a concurrent private placement at the same price, adding $7.5 million. The stock begins trading July 24 on Nasdaq under 'SCTX,' and the offering is expected to close on July 27. The upsizing and high-end pricing signal robust institutional interest and strategic partner confidence for the clinical-stage CRISPR biotech advancing a lead candidate for cardiometabolic disease.

This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SCTX - Latest Insights

SCTX
Nov 12, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.99
Real-time Price: $12.00 info
Change: -$4.99 (-29%) info
Market Cap: $228.576M info
SCTX
Sep 02, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.90
Real-time Price: $12.00 info
Change: -$18.90 (-61%) info
Market Cap: $228.576M info
SCTX
Sep 02, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.90
Real-time Price: $12.00 info
Change: -$18.90 (-61%) info
Market Cap: $228.576M info
SCTX
Jul 30, 2026, 9:30 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $22.46
Real-time Price: $12.00 info
Change: -$10.46 (-47%) info
Market Cap: $228.576M info
SCTX
Jul 30, 2026, 4:39 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $23.00
Real-time Price: $12.00 info
Change: -$11.00 (-48%) info
Market Cap: $228.576M info